These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 20110790)

  • 21. Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge.
    Dalbeth N; House ME; Gamble GD; Pool B; Horne A; Purvis L; Stewart A; Merriman M; Cadzow M; Phipps-Green A; Merriman TR
    Arthritis Res Ther; 2014 Jan; 16(1):R34. PubMed ID: 24476385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study.
    Zhang L; Spencer KL; Voruganti VS; Jorgensen NW; Fornage M; Best LG; Brown-Gentry KD; Cole SA; Crawford DC; Deelman E; Franceschini N; Gaffo AL; Glenn KR; Heiss G; Jenny NS; Kottgen A; Li Q; Liu K; Matise TC; North KE; Umans JG; Kao WH
    Am J Epidemiol; 2013 May; 177(9):923-32. PubMed ID: 23552988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
    Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
    Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.
    Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Ikebuchi Y; Ito K; Kusanagi Y; Chiba T; Tadokoro S; Takada Y; Oikawa Y; Inoue H; Suzuki K; Okada R; Nishiyama J; Domoto H; Watanabe S; Fujita M; Morimoto Y; Naito M; Nishio K; Hishida A; Wakai K; Asai Y; Niwa K; Kamakura K; Nonoyama S; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Hamajima N; Shinomiya N
    Sci Transl Med; 2009 Nov; 1(5):5ra11. PubMed ID: 20368174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout.
    Kawamura Y; Nakaoka H; Nakayama A; Okada Y; Yamamoto K; Higashino T; Sakiyama M; Shimizu T; Ooyama H; Ooyama K; Nagase M; Hidaka Y; Shirahama Y; Hosomichi K; Nishida Y; Shimoshikiryo I; Hishida A; Katsuura-Kamano S; Shimizu S; Kawaguchi M; Uemura H; Ibusuki R; Hara M; Naito M; Takao M; Nakajima M; Iwasawa S; Nakashima H; Ohnaka K; Nakamura T; Stiburkova B; Merriman TR; Nakatochi M; Ichihara S; Yokota M; Takada T; Saitoh T; Kamatani Y; Takahashi A; Arisawa K; Takezaki T; Tanaka K; Wakai K; Kubo M; Hosoya T; Ichida K; Inoue I; Shinomiya N; Matsuo H
    Ann Rheum Dis; 2019 Oct; 78(10):1430-1437. PubMed ID: 31289104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study.
    Chang YS; Lin CY; Liu TY; Huang CM; Chung CC; Chen YC; Tsai FJ; Chang JG; Chang SJ
    Arthritis Res Ther; 2022 Oct; 24(1):229. PubMed ID: 36221101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study.
    Tabara Y; Kohara K; Kawamoto R; Hiura Y; Nishimura K; Morisaki T; Kokubo Y; Okamura T; Tomoike H; Iwai N; Miki T
    Am J Nephrol; 2010; 32(3):279-286. PubMed ID: 20714133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-specific association between ABCG2 variants and tophaceous disease in people with gout.
    He W; Phipps-Green A; Stamp LK; Merriman TR; Dalbeth N
    Arthritis Res Ther; 2017 Mar; 19(1):43. PubMed ID: 28270222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The epidemiology and genetic of gout].
    Bardin T; Richette P
    Presse Med; 2011 Sep; 40(9 Pt 1):830-5. PubMed ID: 21752574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.
    Nakayama A; Matsuo H; Nakaoka H; Nakamura T; Nakashima H; Takada Y; Oikawa Y; Takada T; Sakiyama M; Shimizu S; Kawamura Y; Chiba T; Abe J; Wakai K; Kawai S; Okada R; Tamura T; Shichijo Y; Akashi A; Suzuki H; Hosoya T; Sakurai Y; Ichida K; Shinomiya N
    Sci Rep; 2014 Jun; 4():5227. PubMed ID: 24909660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
    Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
    Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
    Dehghan A; Köttgen A; Yang Q; Hwang SJ; Kao WL; Rivadeneira F; Boerwinkle E; Levy D; Hofman A; Astor BC; Benjamin EJ; van Duijn CM; Witteman JC; Coresh J; Fox CS
    Lancet; 2008 Dec; 372(9654):1953-61. PubMed ID: 18834626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Characterization of Clinically-Relevant Rare Variants in
    Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
    Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
    Wen CC; Yee SW; Liang X; Hoffmann TJ; Kvale MN; Banda Y; Jorgenson E; Schaefer C; Risch N; Giacomini KM
    Clin Pharmacol Ther; 2015 May; 97(5):518-25. PubMed ID: 25676789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
    Eckenstaler R; Benndorf RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion.
    Torres RJ; de Miguel E; Bailén R; Banegas JR; Puig JG
    J Rheumatol; 2014 Sep; 41(9):1863-70. PubMed ID: 25128519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people.
    Yamagishi K; Tanigawa T; Kitamura A; Köttgen A; Folsom AR; Iso H;
    Rheumatology (Oxford); 2010 Aug; 49(8):1461-5. PubMed ID: 20421215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex and age interaction with genetic association of atherogenic uric acid concentrations.
    Brandstätter A; Lamina C; Kiechl S; Hunt SC; Coassin S; Paulweber B; Kramer F; Summerer M; Willeit J; Kedenko L; Adams TD; Kronenberg F
    Atherosclerosis; 2010 Jun; 210(2):474-8. PubMed ID: 20053405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
    Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
    Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.